MYDA Advisors’s ProKidney PROK Stock Holding History

MYDA Advisors’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Buy	640,775 +212,000	+49%	+$388K	0.19%	98
2026 Q1	$768K	Sell	428,775 -11,225	-3%	-$23.8K	0.13%	115
2025 Q4	$986K	Sell	440,000 -10,000	-2%	-$26.3K	0.19%	86
2025 Q3	$1.09M	Buy	+450,000	New	+$1.2M	0.24%	89
2022 Q3	–	Sell	-232,000	Closed	-$2.31M	–	195
2022 Q2	$2.31M	Hold	232,000	–	–	0.65%	35
2022 Q1	$2.3M	Hold	232,000	–	–	0.91%	36
2021 Q4	$2.3M	Sell	232,000 -723	-0.3%	-$7.15K	0.61%	46
2021 Q3	$2.28M	Hold	232,723	–	–	0.64%	42
2021 Q2	$2.35M	Buy	+232,723	New	+$2.35M	0.59%	48

Other funds holding PROK

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MYDA Advisors's PROK Position: Q2 2026 in Review

MYDA Advisors increased its ProKidney (PROK) stake by 49% in Q2 2026, buying an estimated $388K and bringing the position to 640,775 shares worth $1.31M. The position accounts for 0.19% of the portfolio, ranked #98.

MYDA Advisors first reported a position in PROK in Q2 2021 and has held it in 9 quarters since. The position peaked at $2.35M in Q2 2021. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

MYDA Advisors held 640,775 shares of ProKidney worth $1.31M as of Q2 2026.
MYDA Advisors bought 212,000 ProKidney shares in Q2 2026, an estimated $388K.
ProKidney made up 0.19% of MYDA Advisors's portfolio in Q2 2026, its #98 holding.
MYDA Advisors first reported a position in ProKidney in Q2 2021 and has held it in 9 quarters since.
MYDA Advisors's ProKidney position peaked at $2.35M in Q2 2021.
71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on MYDA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.